Market pressures weigh heavy on medtech in 2013, with M&A activity down 16% and FDA approvals down 44% year-over-year, but at least it wasn't the decade's worst period.
Last year was a tough one for the medical device industry, with acquisition activity down, M&A dollars cut in half and FDA approvals slashed, but at least it wasn't the worst year that medtech has faced in the last decade – 2009 still holds that title.
News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Mergers & Acquisitions, Pre-Market Approval (PMA), Trends
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1ga5M6z
Cap comentari:
Publica un comentari a l'entrada